Cargando…

Effect of vaccination with N-glycolyl GM3/VSSP vaccine by subcutaneous injection in patients with advanced cutaneous melanoma

NeuGc-containing gangliosides have been described in melanoma cells and are an attractive target for cancer immunotherapy because they are minimally or not expressed in normal human tissues. Melanoma patients treated with a vaccine based on N-glycolyl gangliosides have shown benefit in progression f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Osorio, Marta, Gracia, Elias, Reigosa, Edmundo, Hernandez, Julio, de la Torre, Ana, Saurez, Giselle, Perez, Kirenia, Viada, Carmen, Cepeda, Meylán, Carr, Adriana, Ávila, Yisel, Rodríguez, Migdalia, Fernandez, Luis E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2012
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468021/ https://www.ncbi.nlm.nih.gov/pubmed/23055778 http://dx.doi.org/10.2147/CMAR.S22617

Ejemplares similares

NGlycolylGM3/VSSP Vaccine in Metastatic Breast Cancer Patients: Results of Phase I/IIa Clinical Trial
por: de la Torre, Ana, et al.
Publicado: (2012)

Superior Efficacy and Safety of a Nonemulsive Variant of the NGcGM3/VSSP Vaccine in Advanced Breast Cancer Patients
por: de la Torre, Ana, et al.
Publicado: (2016)

Prognostic Significance of N-Glycolyl GM3 Ganglioside Expression in Non-Small Cell Lung Carcinoma Patients: New Evidences
por: Blanco, Rancés, et al.
Publicado: (2015)

Immunoreactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Primary Lymphoid Tumors and Lymph Node Metastasis
por: Blanco, Rancés, et al.
Publicado: (2013)

Tissue Reactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Tumors of Neuroectodermal, Mesodermal, and Epithelial Origin
por: Blanco, Rancés, et al.
Publicado: (2013)

Aberrant expression of N-glycolyl GM3 ganglioside is associated with the aggressive biological behavior of human sarcomas
por: Pilco-Janeta, Daniel, et al.
Publicado: (2019)

Detection of N-Glycolyl GM3 Ganglioside in Neuroectodermal Tumors by Immunohistochemistry: An Attractive Vaccine Target for Aggressive Pediatric Cancer
por: Scursoni, Alejandra M., et al.
Publicado: (2011)

Prognostic Role of 14F7 Mab Immunoreactivity against N-Glycolyl GM3 Ganglioside in Colon Cancer
por: Lahera, Tania, et al.
Publicado: (2014)

Immunoreactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Epithelial Malignant Tumors from Digestive System
por: Blanco, Rancés, et al.
Publicado: (2011)

Immunohistochemical Reactivity of the 14F7 Monoclonal Antibody Raised against N-Glycolyl GM3 Ganglioside in Some Benign and Malignant Skin Neoplasms
por: Blanco, Rancés, et al.
Publicado: (2011)

Racotumomab: an anti-idiotype vaccine related to N-glycolyl-containing gangliosides – preclinical and clinical data
por: Vázquez, Ana M., et al.
Publicado: (2012)

Immunoreactivity of the 14F7 Mab (Raised against N-Glycolyl GM3 Ganglioside) as a Positive Prognostic Factor in Non-Small-Cell Lung Cancer
por: Blanco, Rancés, et al.
Publicado: (2012)

VSSP-activated macrophages mediate senescence and tumor inhibition in a preclinical model of advanced prostate cancer
por: Alvarez-Arzola, Rydell, et al.
Publicado: (2023)

SILAC-based quantitative proteomics and microscopy analysis of cancer cells treated with the N-glycolyl GM3-specific anti-tumor antibody 14F7
por: Bousquet, Paula A., et al.
Publicado: (2022)

Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide
por: Coulombe, François, et al.
Publicado: (2009)

N-glycolyl chondroitin synthesis using metabolically engineered E. coli
por: Awofiranye, Adeola E., et al.
Publicado: (2020)

Behavior of glycolylated sialoglycans in the binding pockets of murine and human CD22
por: Di Carluccio, Cristina, et al.
Publicado: (2020)

Nimotuzumab as a radiosensitizing agent in the treatment of high grade glioma: challenges and opportunities
por: Diaz-Miqueli, Arlhee, et al.
Publicado: (2013)

Optimized Polyethylene Glycolylated Polymer–Lipid Hybrid Nanoparticles as a Potential Breast Cancer Treatment
por: Massadeh, Salam, et al.
Publicado: (2020)

Tissue micro array analysis of ganglioside N-glycolyl GM3 expression and signal transducer and activator of transcription (STAT)-3 activation in relation to dendritic cell infiltration and microvessel density in non-small cell lung cancer
por: van Cruijsen, Hester, et al.
Publicado: (2009)

Post-vaccination subcutaneous aluminum granuloma
por: Miyachi, Hideaki, et al.
Publicado: (2020)

Subcutaneous vaccine administration – an outmoded practice
por: Cook, Ian F.
Publicado: (2020)

NGcGM3 Ganglioside: A Privileged Target for Cancer Vaccines
por: Fernandez, Luis E., et al.
Publicado: (2010)

Effect of AcHERV-GmCSF as an Influenza Virus Vaccine Adjuvant
por: Choi, Hyo Jung, et al.
Publicado: (2015)

Inadvertent subcutaneous injection of COVID-19 vaccine
por: Ng, Jia Yu
Publicado: (2021)

Early Murine T-lymphocyte Activation Is Accompanied by a Switch from N-Glycolyl- to N-Acetyl-neuraminic Acid and Generation of Ligands for Siglec-E
por: Redelinghuys, Pierre, et al.
Publicado: (2011)

Exogenous incorporation of neugc-rich mucin augments n-glycolyl sialic acid content and promotes malignant phenotype in mouse tumor cell lines
por: Gabri, Mariano R, et al.
Publicado: (2009)

Development of Membrane-Bound GM-CSF and IL-18 as an Effective Tumor Vaccine
por: Huang, Chien-Chiao, et al.
Publicado: (2015)

GM-CSF improves the immune response to the diphtheria-component in a multivalent vaccine
por: Grasse, Marco, et al.
Publicado: (2018)

GM‐CSF is key in the efficacy of vaccine‐induced reduction of Helicobacter pylori infection
por: Vaillant, Laurie, et al.
Publicado: (2022)

Optimizing DC Vaccination by Combination With Oncolytic Adenovirus Coexpressing IL-12 and GM-CSF
por: Zhang, Song-Nan, et al.
Publicado: (2011)

Effect of Multiple Vaccinations with Tumor Cell-Based Vaccine with Codon-Modified GM-CSF on Tumor Growth in a Mouse Model
por: Qiu, Jiantai Timothy, et al.
Publicado: (2019)

Note on the Production of Agglutinins in the Blood of Individuals after Peroral and Subcutaneous Vaccination by Typhoid and Paratyphoid Vaccines
por: Somasekhar, E.
Publicado: (1940)

A Comparative Study of the Intradermal and Subcutaneous Methods for Typhoid Vaccination
por: Leibovitz, Albert
Publicado: (1943)

Toxicity Study of Streptococcus pneumoniae Vaccine Administrated Subcutaneously in Rats
por: Park, Sin Jeong, et al.
Publicado: (2011)

Subcutaneous Immunization of Dogs With Bordetella bronchiseptica Bacterial Ghost Vaccine
por: Muhammad, Abbas, et al.
Publicado: (2019)

Delivering an Immunocastration Vaccine via a Novel Subcutaneous Implant
por: Curtis, Andrew K., et al.
Publicado: (2022)

The response of mute swans (Cygnus olor, Gm. 1789) to vaccination against avian influenza with an inactivated H5N2 vaccine
por: Dolka, Beata, et al.
Publicado: (2016)

Chemo-Enzymatic Synthesis of Glycolyl-Ester-Linked Taxol-Monosaccharide Conjugate and Its Drug Delivery System Using Hepatitis B Virus Envelope L Bio-Nanocapsules
por: Shimoda, Kei, et al.
Publicado: (2012)

Preclinical evaluation of racotumomab, an anti-idiotype monoclonal antibody to N-glycolyl-containing gangliosides, with or without chemotherapy in a mouse model of non-small cell lung cancer
por: Segatori, Valeria I., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_vdghspinkmsd32k6ca2h4hffpu